These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31887768)

  • 1. Microbiology of Cystic Fibrosis Airway Disease.
    Blanchard AC; Waters VJ
    Semin Respir Crit Care Med; 2019 Dec; 40(6):727-736. PubMed ID: 31887768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial Interactions in the Cystic Fibrosis Airway.
    Granchelli AM; Adler FR; Keogh RH; Kartsonaki C; Cox DR; Liou TG
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
    Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging and emerging pathogens in cystic fibrosis.
    de Vrankrijker AM; Wolfs TF; van der Ent CK
    Paediatr Respir Rev; 2010 Dec; 11(4):246-54. PubMed ID: 21109184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern.
    Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S
    Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in patients with cystic fibrosis: diagnostic microbiology update.
    Gilligan PH
    Clin Lab Med; 2014 Jun; 34(2):197-217. PubMed ID: 24856524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future.
    Thornton CS; Parkins MD
    Semin Respir Crit Care Med; 2023 Apr; 44(2):269-286. PubMed ID: 36623820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis].
    Oliver A; Alarcón T; Caballero E; Cantón R
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):89-104. PubMed ID: 19232782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
    Tümmler B; Kiewitz C
    Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.
    Saiman L; Waters V; LiPuma JJ; Hoffman LR; Alby K; Zhang SX; Yau YC; Downey DG; Sermet-Gaudelus I; Bouchara J-P; Kidd TJ; Bell SC; Brown AW
    Clin Microbiol Rev; 2024 Sep; 37(3):e0021521. PubMed ID: 39158301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
    Anzaudo MM; Busquets NP; Ronchi S; Mayoral C
    Rev Argent Microbiol; 2005; 37(3):129-34. PubMed ID: 16323660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis.
    Parkins MD; Floto RA
    J Cyst Fibros; 2015 May; 14(3):293-304. PubMed ID: 25881770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity of microbes associated with cystic fibrosis.
    Hutchison ML; Govan JR
    Microbes Infect; 1999 Oct; 1(12):1005-14. PubMed ID: 10617932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.
    Cios K; Cohen B; Quittell LM; Liu J; Larson EL
    Am J Infect Control; 2019 Jul; 47(7):750-754. PubMed ID: 30732978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.